Filing Flows › Charles River Laboratories International (CRL) › Q1 2026
Charles River Laboratories International (CRL) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 7, 2026
Charles River Laboratories International (CRL) reported revenue of $996M for the first quarter 2026 (Q1 2026), +1% from a year earlier and +0.2% from the quarter before. Operating margin was 12.0%, net loss $14.8M (1.5% of revenue).
Charles River Laboratories International, Q1 2026: revenue $996M (+1% year over year), operating margin 12.0%, net loss $14.8M, operating cash flow $41.1M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $996M | +0.2% | +1% |
| Operating profit | $120M | — | +61% |
| Net earnings | −$14.8M | — | -158% |
| Operating cash flow | $41.1M | -72% | -76% |
What changed
Revenue was $995.8M in Q1 2026, up 1% year over year and roughly flat from the previous quarter. DSA was the largest line at 60% of revenue. Manufacturing added $12.1M year over year (up 7%), 103% of the total change. RMS declined 2%.
Operating profit was $119.9M, a 12.0% margin (up 4.5 points year over year). Of the extra revenue versus Q1 2025, 388% reached operating profit, above the 8% margin then. Total costs fell 4% while revenue rose 1%. The quarter ended with a net loss of $14.8M, narrower than the previous quarter's $276.3M loss. Net interest and other expense of $149.8M was the main reason.
Operating cash flow was $41.1M (down 76% year over year). Non-cash charges added back $67.2M of depreciation and amortization and $22.4M of share-based compensation. Working capital and other items used $33.7M. Capital expenditures of $55.9M exceeded it, leaving free cash flow of −$14.8M.
Questions
What was Charles River Laboratories International's revenue in the first quarter 2026?
Charles River Laboratories International (CRL) reported revenue of $996M for the first quarter 2026 (Q1 2026), +1% from a year earlier and +0.2% from the quarter before.
Was Charles River Laboratories International profitable in the first quarter 2026?
Operating profit was $120M (12.0% of revenue) and net loss $14.8M.
Source: Charles River Laboratories International 10-Q on SEC EDGAR.